Application no. and date | 14157373.3 (espacenet) (Federated) (European Patent Register), 20140228 | Patent/reg. no. and date | DK/EP 2777689, 20150527 | Publication date | 20140917 | Priority no. and date | WO PCT/GB2013/050654, 20130315 | EP pub. no. and date |
EP 2777689 20140917 | Effective date | | Applicant/owner | Advantice Health AB, Gustavlundsvägen 42, 5 tr
167 51 Bromma, SE | Applicant ref. no. | P56217DK01 | Inventor | Karlsson, Ewa, Gustavslundsvägen 42, 5 tr
SE-167 51 Bromma, SE, Ashkar, Sahar Feizollahi, Gustavslundsvägen 42, 5 tr
SE-167 51 Bromma, SE, Kaufmann, Peter, Gustavslundsvägen 42, 5 tr
SE-167 51 Bromma, SE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 47/10 (2006.01) , A61K 47/12 (2006.01) , A61K 47/18 (2006.01) , A61K 8/34 (2006.01) , A61K 8/36 (2006.01) , A61K 8/42 (2006.01) , A61K 9/00 (2006.01) , A61P 17/06 (2006.01) , A61Q 19/00 (2006.01) | Title | Ny farmaceutisk sammensætning til behandling af svampeinfektioner | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|